Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for pain in opioid-tolerant spine surgery patients
NCT04220489Phase 2Terminated
- Start
- Dec 2019
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in postoperative pain. Primary endpoint: Post-surgical Hydromorphone Patient Care Assistance Opioid Utilization at 72 hours. Started Dec 2019; status: terminated.
02
Drugs
ketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04220489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04220489.